Global Cell Therapy Raw Materials Market Expected to Reach USD 48.04 Billion by 2034
02 avr. 2024 12h55 HE
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Raw Materials Market Analysis & Forecast to 2024-2034: Market By Product; By End-user; and By Region" report has been added to...
HNL Lab Medicine Unveils Lifesaving Cellular Therapy Laboratory
01 avr. 2024 14h01 HE
|
Health Network Laboratories (HNL Lab Medicine)
HNL Lab Medicine partners with LVHN to open cellular therapy laboratory, first in Lehigh Valley; capable of apheresis collections and stem cell processing
Global GMP Cell Therapy Consumables Market Projected to Reach $18.25 Billion in 2024, with Continued Growth through 2028
28 mars 2024 18h11 HE
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "GMP Cell Therapy Consumables Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Growth DriversThe latest...
Global CAR-T Cell Therapy Market Expected to Surge to USD 34.04 Billion by 2034 with a CAGR of 23.33%
27 mars 2024 08h50 HE
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results
25 mars 2024 17h45 HE
|
Marker Therapeutics
Lead program in patients with lymphoma demonstrated preliminary safety and efficacy results with sustained complete response in first study participant treated with MT-601 (Neldaleucel) following CAR...
Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
22 mars 2024 12h30 HE
|
Marker Therapeutics
HOUSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
21 mars 2024 17h06 HE
|
Turnstone Biologics Corp.
Turnstone reports fourth quarter and full year 2023 financial results and provides recent business highlights.
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
21 mars 2024 16h05 HE
|
Senti Biosciences, Inc.
– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second quarter of 2024 – – Cash and anticipated...
Immatics Announces Full Year 2023 Financial Results and Corporate Update
21 mars 2024 07h00 HE
|
https://immatics.com/
Interim clinical data update on ACTengine® IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objective response rate with median duration of response not reached at median...
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
20 mars 2024 16h05 HE
|
Vor Biopharma
Trem-cel and VCAR33ALLO clinical trial data expected in the second half of 2024VCAR33ALLO granted Fast Track and Orphan Drug Designation by U.S. Food & Drug Administration Cash runway extends into...